Tiglutik is a medication that is used to treat symptoms of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. It is a liquid form of riluzole, which is a drug that has been shown to slow the progression of ALS and improve survival rates in patients with the disease.

Tiglutik is administered orally, making it easier for patients who may have difficulty swallowing or taking pills. It is typically taken twice daily, with or without food. The dosage of Tiglutik will vary depending on the individual patient’s needs and should be determined by a healthcare provider.

As with any medication, Tiglutik may cause side effects. Common side effects of Tiglutik include nausea, dizziness, and fatigue. It is important to discuss any side effects with your healthcare provider to determine if Tiglutik is the right treatment option for you.

It is important to follow your healthcare provider’s instructions when taking Tiglutik and to not stop taking the medication without consulting them first. Tiglutik should be stored at room temperature and away from light and moisture.

Overall, Tiglutik is a valuable treatment option for patients with ALS and has been shown to be effective in slowing the progression of the disease. If you have been diagnosed with ALS, talk to your healthcare provider about whether Tiglutik may be a suitable treatment option for you.